RxDoctor Payments Data

Hayley Steele Schlauderaff, APRN

Family · Silverton, ORNPI 1942965140

Payments from drug & device makers

$907in general payments, 2019–2025

Across 47 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$183
  • Pfizer$154
  • Sanofi Pasteur Inc.$96
  • Biohaven Pharmaceutical Holding Company Ltd.$76
  • Exact Sciences$76
  • AbbVie$66
  • plus $255 from 8 others

What the payments were for

  • Food & beverage$907100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$907 in reported general payments places this provider in the 80th percentile of 1,130 family providers in Oregon.

See all family providers in Oregon

Medicare billing

Part B allowed, 2024
$9,038
Medicare patients
67
Services billed
165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$16,550
Lisinopril36$609
Levothyroxine Sodium30$555
Alendronate Sodium42$529
Rosuvastatin Calcium29$416
Gabapentin14$393
Simvastatin25$385
Amlodipine Besylate25$307
Metformin Hcl12$201
Atorvastatin Calcium27$197
Metoprolol Succinate11$172
Hydrochlorothiazide11$50
Meloxicam14$48

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$154$16,55011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,130 family providers in Oregon.

Other family in Silverton

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →